Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of diluted EPS
                       
    Three Months Ended
September 30,
   

Nine Months Ended

September 30,

 
    2021     2020     2021     2020  
Weighted average common shares outstanding - basic     136,311,335       136,311,335       136,311,335       136,061,140  
Dilutive effect of stock options                        
Weighted average common shares outstanding - diluted     136,311,335       136,311,335       136,311,335       136,061,140  
Schedule of product warranties
           
    September 30,
2021
    December 31,
2020
 
             
Beginning balance   $ 45,328     $ 58,791  
Warranty claims incurred     (14,548 )     (20,499 )
Provision charged (credited) to expense     (13,229 )     7,036  
Ending balance   $ 17,551     $ 45,328